RadNet, Inc. Cash and Restricted Cash
RadNet, Inc. (RDNT) had Cash and Restricted Cash of $726.27 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-10
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $726.27M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $455.34M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $767.22M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $804.72M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $726.27M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $455.34M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $767.22M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $804.72M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $833.15M 10-Q · filed 2026-08-10 | |
| 2025-03-31 | $717.32M 10-Q · filed 2026-05-11 | |
| 2024-12-31 | $740.02M 10-Q · filed 2026-08-10 | |
| 2024-09-30 | $748.92M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $741.68M 10-Q · filed 2025-08-11 | |
| 2024-03-31 | $526.98M 10-Q · filed 2025-05-12 | |
| 2023-12-31 | $342.57M 10-K · filed 2026-03-02 | |
| 2023-09-30 | $337.88M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $356.65M 10-Q · filed 2024-08-09 | |
| 2023-03-31 | $90.84M 10-Q · filed 2024-05-10 | |
| 2022-12-31 | $127.83M 10-K · filed 2026-03-02 | |
| 2022-09-30 | $95.01M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $99.17M 10-Q · filed 2023-08-09 | |
| 2022-03-31 | $70.71M 10-Q · filed 2023-05-10 | |
| 2021-12-31 | $134.61M 10-K · filed 2025-03-03 | |
| 2021-09-30 | $151.25M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $140.85M 10-Q · filed 2022-08-09 | |
| 2021-03-31 | $31.09M 10-Q · filed 2022-05-10 | |
| 2020-12-31 | $102.02M 10-K · filed 2024-02-29 | |
| 2020-09-30 | $88.74M 10-Q · filed 2021-11-09 | $89.74M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $84.58M 10-Q · filed 2021-08-09 | |
| 2020-03-31 | $94.28M 10-Q · filed 2021-05-10 | |
| 2019-12-31 | $40.16M 10-K · filed 2023-03-01 | |
| 2019-09-30 | $37.69M 10-Q · filed 2020-11-09 | |
| 2018-12-31 | $10.39M 10-K · filed 2022-03-01 | |
| 2017-12-31 | $51.32M 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |